New paper out by myself, @LauraJDowney, @zaina_mahmoud94, & @JeanMcHale2. Setting out where we are with medical devices regulation in the UK, how we got here, & where we might be going.

Later today, presenting some work on psychedelics. Based on a chapter I have written with Dr Matt Hayler (English Lit @ UoB)

@PatentsInHumans Prof Aisling McMahon & Dr Opeyemi Kolawole article just out #MedicalLawReview on 'Biobank Donation in search of public benefits & Potential impact of IPRs over access to health technologies developed: A focus on bioethical implications' https://t.co/pmMbX9Lhq8

Developing Esketamine (Spravato) and Lessons for Psychedelic Drug Developers with Jaskaran Singh https://t.co/FMWd0KDhOV

Really excited to see this published today in @MedLawInt - my latest article considering the construction of the best interests of women with a SMI in the obstetric context and the untapped potential of advance decisions.

ICER Draft Evidence Report on Lykos’ MDMA-Assisted Psychotherapy Deems Clinical Evidence “Insufficient” https://t.co/uGr5BgmCqU

MindMed becomes the fourth organisation to receive such FDA Breakthrough Therapy Designation for a psychedelic drug candidate. Previously, MAPS, Compass Pathways and Usona Institute received the designation, for MDMA and psilocybin (x2), respectively.

FDA Hands MindMed's LSD Candidate Breakthrough Therapy Designation in Generalised Anxiety Disorder; Company Provides 12-Week Data and Fleshes Out Phase 3 Program Plans Our coverage: https://t.co/w3Nod0DcW7

Pα+ Psychedelic Bulletin #157: Psilocybin for Generalised Anxiety Disorder; Uptick in Psilocybin-Related Poison Centre Calls https://t.co/hghRqthPaV

The next @CHLSPBIRMINGHAM Zoom seminar will be held on Thursday 7th March at 13:00. @sabrinakgermain & Emily Allbon @CityLawSchool & Mara Malagodi @Warwick_Law are giving the paper “Reproductive Rights as Socio-Economic Rights in Nepal” All very welcome!

Colorado’s Draft Natural Medicine Rules: A High-Level Overview The first draft rules for CO's regulated psychedelics market were revealed on Feb 16th. The folks at Vicente LLP have parsed through the 39-page draft rules to provide a concise overview. https://t.co/vF7WHgogDP

Emma Cave @profEmmaCave @DurhamLawSchool @durham_uni discusses how the sufficiency of young adults’ autonomy is judged in light of biological, social and psychological evidence that #adolescence can continue into the mid 20s https://t.co/7CeJ9pLM1a #law #medicallaw

A brief thread about a new paper by me on neurotech & human rights. Right at the time when #Neuralink reports its first in-human brain-computer interface implant (which is btw not the first brain implant, but a new device implanted through a new method)../ https://t.co/ulPsKkJ5Lo

We are looking for two new associate editors! Pls RT and get in touch if you have any questions ✨

Bullseye Chart: The Psychedelic Drug Development Pipeline @MichaelHaichin and @NoahJSmith98 have produced the latest iteration of our psychedelic drug dev. bullseye chart. Access and download the full-size chart here: https://t.co/aR55ddafMF

Good news - today is NOT the last day to submit an abstract to this unmissable event! There's another couple of weeks to do so! @ilagalasso @SErikainen @PickersgillM

Interview: Compass Pathways $CMPS CEO Kabir Nath Discusses Commercialisation, ‘Psychological Support’ and Competitive Landscape https://t.co/mUFft8KGvS

So much yes to all of this. Relevant not just for privacy law scholarship, but all of it!

Over the weekend, the first Home Office-licensed, local government-commissioned, fully funded, regular drug testing service launched in Bristol city centre. This finally marks the end of the pilot stage of drug testing facilities. ✊ Read in thread 🧵

Medical Law International is recruiting two new associate editors to join our team (alongside the new co-EICs @israblack @alex_mullock @ECRomanis & Sarah Devaney) information below 👇 Pls share widely and get in touch if you want to discuss!